(Q57613985)

3

0 references

Emanuela Medda

object named as

E. Medda

2

0 references

author name string

S. Barile

1

0 references

P. Cordiali-Fei

5

0 references

M. Carducci

6

0 references

A. Rainaldi

7

0 references

R. Marinelli

8

0 references

C. Bonifati

Angiogenesis in psoriasis.

9

0 references

publication date

May 2006

0 references

published in

Experimental Dermatology

0 references

volume

15

0 references

issue

5

0 references

page(s)

368-376

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Photochemotherapy inhibits angiogenesis and induces apoptosis of endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Insulin-like growth factor-II regulates the expression of vascular endothelial growth factor by the human keratinocyte cell line HaCaT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Differential control of VEGF synthesis and secretion in human glioma cells by IL-1 and EGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Interleukin 6 induces the expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

21 January 2018

Cytokines in psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Neovastat (AE-941), an inhibitor of angiogenesis: Randomized phase I/II clinical trial results in patients with plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Vascular endothelial growth factor gene variability is associated with increased risk for AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Cytokine gene polymorphisms in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Lack of association between the promoter polymorphisms at positions -308 and -238 of the tumor necrosis factor alpha gene and psoriasis vulgaris in Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Association of TNF -238 and -308 Promoter Polymorphisms with Psoriasis Vulgaris and Psoriatic Arthritis but not with Pustulosis Palmoplantaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Replication validity of genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X

Promoter Polymorphisms of the Genes Encoding Tumor Necrosis Factor-α and Interleukin-1β are Associated with Different Subtypes of Psoriasis Characterized by Early and Late Disease Onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2006.00416.X